拥护 发表于 2025-3-25 04:01:48

http://reply.papertrans.cn/2/149/14805/14805-21.png

完成 发表于 2025-3-25 10:52:22

Submitted on: 02 November 2008.
Revised on: 26 November 2008.
Accepted on: 06 January 2009.

___________________JAMA Ophthalmology---AMER MEDICAL ASSOC

badinage 发表于 2025-3-25 14:58:13

Submitted on: 27 September 2010.
Revised on: 11 November 2010.
Accepted on: 02 December 2010.

___________________JAMA Ophthalmology---AMER MEDICAL ASSOC

Engaging 发表于 2025-3-25 16:19:38

http://reply.papertrans.cn/2/149/14805/14805-24.png

补角 发表于 2025-3-25 21:24:34

http://reply.papertrans.cn/2/149/14805/14805-25.png

ascend 发表于 2025-3-26 00:23:12

http://reply.papertrans.cn/2/149/14805/14805-26.png

macular-edema 发表于 2025-3-26 06:00:32

http://reply.papertrans.cn/2/149/14805/14805-27.png

深渊 发表于 2025-3-26 09:49:26

http://reply.papertrans.cn/2/149/14805/14805-28.png

leniency 发表于 2025-3-26 13:57:28

Submitted on: 29 April 2006.
Revised on: 22 August 2006.
Accepted on: 15 September 2006.

___________________JAMA Ophthalmology---AMER MEDICAL ASSOC

Neutropenia 发表于 2025-3-26 18:34:05

http://reply.papertrans.cn/2/149/14805/14805-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊JAMA Ophthalmology 2024/2025影响因子:7.841 (JAMA OPHTHALMOL) (2168-6165). (OPHTHALMOLOGY)(眼科学)Science Citation Index